Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
Clinical trial NCT02052739 · COMPLETED
Trial details
- NCT number
- NCT02052739
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-21
- Primary completion
- 2015-05-03
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.